セッション情報

一般演題 (示説)

第53回・2015年・京都
一般演題 (示説)
示説23
Breast:Breast Cancer
開催回
第53回・2015年・京都

Analysis of in situ expression of hormone receptors and proliferation marker at a single cell level in breast cancer tissues

演題番号 : P23-1

Ueno Takayuki:1、Isaka Hirotugu:1、Itoh Hiroki:1、Imi Kentaro:1、Miyamoto Kaisuke:1、Kitamura Manami:1、Imoto Shigeru:1

1:Dept. of Breast Surgery, Hospital, Kyorin University

Analysis of in situ expression of hormone receptors and proliferation marker at a single cell level in breast cancer tissues

Response to treatment and prognosis of recurrent breast cancer patients with receptor discordance

演題番号 : P23-2

Harada Hanako:1、Jinno Hirokitsu:3、Yokoe Takamichi:1、Takemae Masaru:1、Kurihara Toshoaki:1、Takahashi Maiko:2、Hayashida Tetsu:1、Kitagawa Yuko:1

1:Department of Surgery, School of Medicine, Keio University、2:Oncology center, Hospital, Keio University、3:Department of Surgery, School of Medicine, Teikyo University

Response to treatment and prognosis of recurrent breast cancer patients with receptor discordance

The efficacy of aloe-emodin co-treat with five different current anticancer drugs, tamoxifen, trastuzumab, 5-fluoracil, epirubicin and paclitaxel in breast carcinoma cells BT-474

演題番号 : P23-3

Yu Xin-xuan:1、Chen Dar-ren:1,2、Lin Hui-yi:3

1:Cancer Research Center, Changhua Christian Hospital, Changhua City, Taiwan、2:Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua City, Taiwan、3:School of Pharmacy, China Medical University, Taichung City, Taiwan

The efficacy of aloe-emodin co-treat with five different current anticancer drugs, tamoxifen, trastuzumab, 5-fluoracil, epirubicin and paclitaxel in breast carcinoma cells BT-474

Dual expression of Aquaporin 3 and 5 in patients with early breast cancer

演題番号 : P23-4

Chae Yeesoo:1、Lee Soo Jung:1、Kim Jong Gwang:1、Jung Jin Hyang:2、Park Ho Yong:2、Jeong Jae-hwan:2、Lee Jeeyeon:2、Kim Wan Wook:2、Park Ji-young:3、Jeong Ji Yun:3

1:INTERNAL MEDICINE, MEDICAL ONCOLOGY, KYUNGPOOK NATIONAL UNIVERSITY SCHOOL OF MEDICINE、2:SURGERY, BREAST SURGERY, KYUNGPOOK NATIONAL UNIVERSITY SCHOOL OF MEDICINE、3:PATHOLOGY, KYUNGPOOK NATIONAL UNIVERSITY SCHOOL OF MEDICINE

Dual expression of Aquaporin 3 and 5 in patients with early breast cancer

Clinical efficacy of neoadjuvant chemotherapy for HER2 negative breast cancer analyzed by contrast-enhanced breast ultrasound

演題番号 : P23-5

Kanazawa Shinsaku:1、Ogata Hideaki:2、Mitsuzuka Yukio:3、Kato Ryouji:1

1:Department of Surgery (Sakura), Sakura medical Center, Toho University、2:Department of Surgery (Omori), Omori Medical Center, Toho University、3:Department of Clinical Functional Physiology, Omori Medical Center, Toho University

Clinical efficacy of neoadjuvant chemotherapy for HER2 negative breast cancer analyzed by contrast-enhanced breast ultrasound

Phase Ib dose-escalation study of eribulin plus capecitabine in metastatic breast cancer

演題番号 : P23-6

Ishiguro Hiroshi:1、Masuda Norikazu:2、Yasojima Hiroyuki:2、Ohtani Shoichiro:3、Yoshimura Akiyo:4、Hattori Masaya:4、Iwata Hiroji:4

1:Department of Target Therapy Oncology, Graduate School of Medicine, Kyoto University、2:Osaka Medical Center, National Hospital Organization、3:Hiroshima City Hospital、4:Aichi Cancer Center Hospital

Phase Ib dose-escalation study of eribulin plus capecitabine in metastatic breast cancer

Ongoing phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components

演題番号 : P23-7

Imoto Shigeru:1、Nagamine Shinji:2、Ito Toshikazu:3、Tsuda Hitoshi:4、Yoshida Masayuki:5、Tozaki Mitsuhiro:6、Morita Satoshi:7、Ueno Takyuki:1

1:Department of Breast Surgery, Hospital, Kyorin University、2:Department of Surgery, Okinawa Red Cross Hospital、3:Department of Surgery, Rinku General Medical Center、4:Department of Surgery, National Defense Medical College、5:Department of Pathology and Clinical Laboratories, National Cancer Center Hospital、6:Breast Center, Kameda Medical Center、7:Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University

Ongoing phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components

Management of axilla in node-positive breast cancer patients with cytologically proven

演題番号 : P23-8

Hayama Shoko:1、Sakakibara Masahiro:1、Nagashima Takeshi:1、Sangai Takafumi:1、Sakakibara Junta:1、Iwase Toshiaki:1、Ishigai Emi:1、Masuda Takahito:1、Miyazaki Masaru:1

1:Department of general surgery, Graduate School, Chiba University

Management of axilla in node-positive breast cancer patients with cytologically proven

BRCAness in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

演題番号 : P23-9

Tanino Hirokazu:1、Sengoku Norihiko:1、Enomoto Takumo:1、Kosaka Yoshimasa:1、Kato Hiroshi:1、Waraya Mina:1、Shida Akiko:1、Kikuchi Mariko:1、Minatani Naoko:1、Nishimiya Hiroshi:1、Watanabe Masahiko:1

1:Dept. Surgery, School of Medicine, Kitazato University

BRCAness in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Comparative effectiveness of neoadjuvant therapy for HER2-Positive breast cancer: A network meta-analysis

演題番号 : P23-10

Yokoe Takamichi:1、Nagayama Aiko:1、Hayashida Tetsu:1、Takahashi Maiko:1、Seki Tomoko:1、Kurihara Toshiaki:1、Harada Hanako:1、Takemae Masashi:1、Kitagawa Yuko:1

1:Department of Surgery, School of Medicine, Keio University

Comparative effectiveness of neoadjuvant therapy for HER2-Positive breast cancer: A network meta-analysis